Table 4.

Effects of treatment on the secondary outcome variables: fat mass, CAVI, HRV, and PhA.

	ERW (n = 29)	MW (n = 24)	p
Outcome Variables	Means ± SD	Means ± SD	Time	Group	Time * Group
Fat Mass-Total (kg)
Baseline	16.21 ± 4.88	17.30 ± 5.03
4 weeks	16.18 ± 5.00	16.55 ± 4.90	0.000	0.678	0.041
8 weeks	15.86 ± 4.86	16.10 ± 5.31
Fat Mass-Visceral (kg)
Baseline	1.86 ± 0.96	2.00 ± 0.95
4 weeks	1.87 ± 1.00	1.87 ± 0.82	0.000	0.846	0.027
8 weeks	1.79 ± 0.94	1.80 ± 0.93
Fat Mass-Subcutaneous (kg)
Baseline	14.36 ± 3.96	15.30 ± 4.12
4 weeks	14.30 ± 4.04	14.69 ± 4.11	0.000	0.644	0.047
8 weeks	14.07 ± 3.96	14.30 ± 4.41
CAVI-Rt
Baseline	6.44 ± 0.80	6.36 ± 1.06
4 weeks	6.32 ± 0.80	6.36 ± 0.73	0.627	0.738	0.615
8 weeks	6.18 ± 0.69	6.36 ± 0.86
CAVI-Lt
Baseline	6.52 ± 0.77	6.48 ± 1.11
4 weeks	6.38 ± 0.83	6.48 ± 0.76	0.444	0.577	0.677
8 weeks	6.23 ± 0.69	6.42 ± 0.81
HRV-PSI
Baseline	71.92 ± 81.46	52.85 ± 31.23
4 weeks	71.54 ± 59.39	54.99 ± 33.62	0.825	0.182	0.765
8 weeks	63.09 ± 41.19	54.68 ± 38.06
HRV-TP (ms2)
Baseline	913.43 ± 613.60	1071.63 ± 876.97
4 weeks	985.86 ± 1030.49	1041.21 ± 1223.80	0.502	0.795	0.851
8 weeks	1185.43 ± 1570.90	1115.73 ± 973.82
HRV-LF/HF
Baseline	1.52 ± 1.30	2.01 ± 2.14
4 weeks	1.64 ± 1.41	1.64 ± 1.79	0.629	0.958	0.197
8 weeks	2.19 ± 2.43	1.64 ± 1.34
Phase Angle (° )
Baseline	5.89 ± 0.85	5.83 ± 0.85
4 weeks	5.63 ± 0.75	5.67 ± 0.78	0.000	0.952	0.566
8 weeks	5.62 ± 0.67	5.60 ± 0.84

Note: * Interaction between Time and the Group. Abbreviations: CAVI, cardio-ankle vascular index; HRV, heart rate variability; PSI, physical stress index; TP, total power; LF, low frequency; HF, high frequency.